Abstract
The objective of recent research has been to seek alternative therapeutic treatments; for this reason, the use of protein hydrolysates from diverse sources has been studied. A way to guarantee that these treatments reach the site of action is through protection with covers, such as microcapsules. Therefore, proteins from the legume Phaseolus lunatus were hydrolyzed and encapsulated with a blend of Delonix regia carboxymethylated gum/sodium alginate (50 : 50 w/w). Hydrolysis release conditions in a simulated gastrointestinal system were obtained using CaCl2 concentrations as the main factor, indicating that lower CaCl2 concentrations lead to an increased hydrolysis release. Beads obtained with 1.0 mM of CaCl2 exhibited a better hydrolysate release rate under intestinal simulated conditions and the proteins maintained an IC50 of 2.9 mg/mL. Capsules obtained with the blend of Delonix regia carboxymethylated gum/sodium alginate would be used for the controlled delivery of hydrolysates with potential use as nutraceutical or therapeutic agents.
Highlights
Enzymatic hydrolysis of food proteins has produced various biologically active peptides with immunostimulating, opioid, antithrombotic, anticariogenic, and bactericidal or angiotensin-converting enzyme (ACE) inhibitory functions and has been the focus of recent research [1]
ACE inhibitors have been prescribed for hypertensive patients worldwide, and many clinical application data have demonstrated that ACE inhibitors significantly reduce the morbidity and mortality of patients with myocardial infarction or heart failure [3]
Recent research has focused on the properties of food protein-derived peptides, their biological activities, and potential health benefits
Summary
Enzymatic hydrolysis of food proteins has produced various biologically active peptides with immunostimulating, opioid, antithrombotic, anticariogenic, and bactericidal or angiotensin-converting enzyme (ACE) inhibitory functions and has been the focus of recent research [1]. The renin angiotensin system plays an important role in blood pressure and in cardiac and vascular functions. Renin produces decapeptide angiotensin I from angiotensinogen. ACE catalyzes the formation of angiotensin II by cleaving the dipeptide from the C-terminal of angiotensin I in the vascular wall [2]. ACE inhibitors may induce skin rashes, angioneurotic edema, diarrhea, cough, and dizziness [4]. Because hypertensive patients often need life-long medical treatment, interest has been focused on the isolation and identification of ACE-inhibitors which may be obtained from new and varied sources like foods [5]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
